Iron isomaltoside 1000: a new intravenous iron for treating iron deficiency in chronic kidney disease.

@article{Wikstrm2011IronI1,
  title={Iron isomaltoside 1000: a new intravenous iron for treating iron deficiency in chronic kidney disease.},
  author={Bj{\"o}rn Wikstr{\"o}m and Sunil Bhandari and Peter Barany and Philip A Kalra and S\oren Ladefoged and Jan Wilske and Lars Lykke Thomsen},
  journal={Journal of nephrology},
  year={2011},
  volume={24 5},
  pages={589-96}
}
BACKGROUND Patients with chronic kidney disease (CKD) often suffer from iron deficiency anemia necessitating treatment with intravenous iron. This study was designed to assess the safety of iron isomaltoside 1000 (Monofer) in CKD patients. The secondary objective was to assess its effect on iron deficiency anemia. METHODS This open-label, noncomparative, multicenter trial assigned 182 patients with CKD (n=161 in dialysis and n=21 in predialysis) to iron isomaltoside 1000 either as 4… CONTINUE READING